Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-41,438
Closed -$3.13M 550
2026
Q1
$3.13M Sell
41,438
-21,191
-34% -$1.59M 0.3% 109
2025
Q4
$4.67M Buy
62,629
+40,444
+182% +$2.96M 0.65% 6
2025
Q3
$1.5M Buy
+22,185
New +$1.47M 0.23% 175
2025
Q2
Sell
-29,600
Closed -$1.83M 525
2025
Q1
$1.83M Buy
29,600
+10,985
+59% +$728K 0.37% 76
2024
Q4
$1.34M Sell
18,615
-395
-2% -$30.9K 0.4% 72
2024
Q3
$1.55M Buy
+19,010
New +$1.52M 0.5% 40
2024
Q1
Sell
-12,281
Closed -$877K 406
2023
Q4
$877K Sell
12,281
-8,915
-42% -$621K 0.25% 160
2023
Q3
$1.47M Buy
21,196
+15,323
+261% +$1.16M 0.43% 43
2023
Q2
$476K Buy
5,873
+108
+2% +$8.83K 0.25% 177
2023
Q1
$465K Buy
5,765
+2,420
+72% +$195K 0.27% 153
2022
Q4
$250K Buy
+3,345
New +$238K 0.54% 99
2022
Q3
Sell
-3,288
Closed -$228K 171
2022
Q2
$228K Buy
+3,288
New +$244K 0.44% 126
2022
Q1
Sell
-10,035
Closed -$768K 445
2021
Q4
$768K Buy
+10,035
New +$738K 0.6% 25

Other funds holding HOLX

Oak Thistle LLC's HOLX Position: Q2 2026 in Review

Oak Thistle LLC sold out of Hologic (HOLX) in Q2 2026, closing a stake of 41,438 shares — an estimated $3.13M sold.

Oak Thistle LLC first reported a position in HOLX in Q4 2021 and held it in 13 quarters. The position peaked at $4.67M in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Oak Thistle LLC reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Oak Thistle LLC sold 41,438 Hologic shares in Q2 2026, an estimated $3.13M.
  • Oak Thistle LLC first reported a position in Hologic in Q4 2021 and held it in 13 quarters.
  • Oak Thistle LLC's Hologic position peaked at $4.67M in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Oak Thistle LLC's 13F filing for Q2 2026, filed 21 Jul 2026.